Not Rated
|
Fund Size
(0.05% of Investment in Category)
|
Expense Ratio
(0.28% Category average)
|
| Period Invested for | ₹10000 Invested on | Latest Value | Absolute Returns | Annualised Returns | Category Avg | Rank within Category |
|---|---|---|---|---|---|---|
| 1 Week | 26-Nov-25 | 9882.10 | -1.18% | - | -0.19% | 316/354 |
| 1 Month | 04-Nov-25 | 10307.60 | 3.08% | - | 0.74% | 35/351 |
| 3 Month | 04-Sep-25 | 10593.40 | 5.93% | - | 3.82% | 84/345 |
| 6 Month | 04-Jun-25 | 11109.80 | 11.10% | - | 3.66% | 11/320 |
| YTD | 31-Dec-24 | 10596.50 | 5.96% | - | 6.85% | 194/282 |
| 1 Year | 04-Dec-24 | 10724.10 | 7.24% | 7.24% | 4.16% | 126/274 |
| 2 Year | 04-Dec-23 | 14123.90 | 41.24% | 18.82% | 11.92% | 8/188 |
| 3 Year | 02-Dec-22 | 16740.70 | 67.41% | 18.68% | 13.61% | 21/132 |
| 5 Year | 04-Dec-20 | 19915.80 | 99.16% | 14.76% | 16.72% | 32/35 |
| Since Inception | 26-Oct-20 | 21532.00 | 115.32% | 16.20% | 9.92% | 66/343 |
| Period Invested for | ₹1000 SIP Started on | Investments | Latest Value | Absolute Returns | Annualised Returns |
|---|---|---|---|---|---|
| 1 Year | 04-Dec-24 | 13000 | 13935.5 | 7.2 % | 14.65 % |
| 2 Year | 04-Dec-23 | 25000 | 28324.67 | 13.3 % | 12.96 % |
| 3 Year | 02-Dec-22 | 37000 | 48079.01 | 29.94 % | 18.17 % |
| 5 Year | 04-Dec-20 | 61000 | 90969.95 | 49.13 % | 16.19 % |
Please check with your Tax Advisor.
Top 10 Stocks in Portfolio
| Stock Invested in | Sector | Value(Mn) | % of Total Holdings | 1M Change | 1Y Highest Holding | 1Y Lowest Holding | Quantity | 1M Change in Qty |
|---|---|---|---|---|---|---|---|---|
| Sun Pharmaceutical Industries Ltd. | Pharmaceuticals | 187.4 | 11.16% | 0.27% | 13.13% (Nov 2024) | 10.84% (Aug 2025) | 1.11 L | -0.31 k |
| Max Healthcare Institute Ltd. | Hospital | 103.1 | 6.14% | -0.03% | 7.08% (Jun 2025) | 5.85% (Nov 2024) | 89.81 k | -0.25 k |
| Cipla Ltd. | Pharmaceuticals | 98 | 5.84% | -0.21% | 6.36% (Aug 2025) | 5.7% (Dec 2024) | 65.30 k | -0.18 k |
| ELI LILLY ORD SHS | Foreign equity | 96.5 | 5.75% | 0.50% | 6.34% (Feb 2025) | 4.86% (May 2025) | 1.26 k | 0.00 |
| Divis Laboratories Ltd. | Pharmaceuticals | 93 | 5.54% | 0.70% | 6.03% (May 2025) | 4.84% (Sep 2025) | 13.80 k | -38.00 |
| Apollo Hospitals Enterprises Ltd. | Hospital | 89.3 | 5.32% | 0.01% | 5.43% (Aug 2025) | 4.75% (Feb 2025) | 11.62 k | -32.00 |
| Dr. Reddys Laboratories Ltd. | Pharmaceuticals | 80.8 | 4.81% | -0.28% | 5.76% (Dec 2024) | 4.81% (Oct 2025) | 67.46 k | -0.19 k |
| Johnson & Johnson | Foreign equity | 63 | 3.75% | -0.05% | 3.8% (Sep 2025) | 2.84% (Dec 2024) | 3.76 k | 0.00 |
| Fortis Healthcare Ltd. | Hospital | 58 | 3.45% | 0.06% | 3.45% (Oct 2025) | 2.32% (Jan 2025) | 56.67 k | -0.16 k |
| AbbVie Inc | Foreign equity | 53.4 | 3.18% | -0.31% | 3.49% (Sep 2025) | 2.49% (Nov 2024) | 2.76 k | 0.00 |
| Name | Type of Instrument | Weight (%) |
|---|---|---|
| TREPS | TREPS | 0.15% |
| Net Receivables | Net Receivables | 0.00% |
Ratios calculated on daily returns for last 3 years (Updated as on 28th November, 2025)
Out of 54 mutual fund schemes offered by this AMC, 1 is/are ranked 5 * , 5 is/are ranked 4 * , 7 is/are ranked 3 * , 1 is/are ranked 2 * , and 40 schemes are not ranked. See more about AMC
| Scheme Name |
Crisil Rank |
Asset Size (Cr) |
1M |
3M |
6M |
1Y |
3Y |
|---|---|---|---|---|---|---|---|
| Edelweiss Arbitrage Fund - Direct Plan - Growth | 3 | 16687.08 | 0.51 | 1.58 | 3.20 | 7.05 | 7.88 |
| Edelweiss Balanced Advantage Fund - Direct Plan - Growth | NA | 13238.71 | 1.16 | 4.37 | 5.21 | 5.84 | 13.21 |
| Edelweiss Mid Cap Fund - Direct Plan - Growth | 5 | 12646.93 | 0.47 | 4.24 | 5.01 | 3.27 | 25.67 |
| Edelweiss Liquid Fund - Direct Plan - Growth | 4 | 10620.71 | 0.49 | 1.48 | 2.99 | 6.72 | 7.11 |
| BHARAT Bond FOF - April 2030 - Direct Plan - Growth | NA | 9647.39 | 0.32 | 2.05 | 2.56 | 8.38 | 8.03 |
| Edelweiss Nifty PSU Bond Plus SDL Apr 2026 50:50 Index Fund - Direct Plan - Growth | NA | 7031.52 | 0.50 | 1.48 | 2.97 | 7.30 | 7.30 |
| Edelweiss Small Cap Fund - Direct Plan - Growth | 4 | 5296.70 | -2.78 | -0.66 | 0.92 | -4.72 | 20.00 |
| BHARAT Bond FOF - April 2031 - Direct Plan - Growth | NA | 4721.85 | 0.57 | 2.37 | 2.33 | 8.72 | 8.15 |
| BHARAT Bond ETF FOF - April 2032 - Direct Plan - Growth | NA | 4517.43 | 0.28 | 2.39 | 1.82 | 8.43 | 8.21 |
| Edelweiss Large and Mid Cap Fund - Direct Plan - Growth | 3 | 4346.62 | 1.41 | 5.22 | 5.34 | 1.82 | 18.78 |